FDA Invites Input As Pharma-Ad Overhaul Looms
The U.S. Food and Drug Administration on Friday invited wide-ranging feedback on its plan to overhaul broadcast advertisements for prescription drugs so that fewer risks are disclosed, the latest chapter in...To view the full article, register now.
Already a subscriber? Click here to view full article